Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. (Q38002494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Massimo Aglietta

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Dario Sangiolo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Lidia Giraudo

1 reference

ORCID Public Data File 2021

author name string

Giulia Mesiano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Maja Todorovic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Loretta Gammaitoni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Valeria Leuci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Lidia Giraudo Diego

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Fabrizio Carnevale-Schianca

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Wanda Piacibello

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

14 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

28 January 2020

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

673-684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

Cell transfer immunotherapy for metastatic solid cancer--what clinicians need to know.

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Preliminary results in children with acute lymphocytic leukemia and neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

The role of the NKG2D immunoreceptor in immune cell activation and natural killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Cellular immunotherapy and autologous transplantation for hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Generation of CD3+ CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Human cytokine-induced killer cells specifically infiltrated and retarded the growth of the inoculated human cholangiocarcinoma cells in SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Inhibition of human cervical carcinoma growth by cytokine-induced killer cells in nude mouse xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Antitumor activity of cytokine-induced killer cells against human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Inhibition of human ovarian tumor growth by cytokine-induced killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Visualizing the kinetics of tumor-cell clearance in living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Cytokine-induced NK-like T cells: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.675323

10.1517/14712598.2012.675323

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22500889%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference